Table 2. Correlations between tumor infiltrating lymphocyte counts and IL-10 haplotype in 87 non-small cell lung cancer patients.

		TIL (count/HPF)
IL-10 haplotype	Case no.	<25	≥25	P value1
All cases
ATA	36	18 (50.0)	18 (50.0)	0.236
Non-ATA	51	32 (62.7)	19 (37.3)
Early stage
ATA	15	7 (46.7)	8 (53.3)	0.988
Non-ATA	28	13 (46.4)	15 (53.0)
Late stage
ATA	21	11 (52.4)	10 (47.6)	0.032
Non-ATA	23	19 (82.6)	4 (17.4)

¹Two sided Chi-square test.